Everything below concerns Albumin binding. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-24. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Enzymatic hydrolysis similar to the body's natural digestive process provides the most efficient breakdown of the proteins into smaller fractions termed peptides which can then be separated from the oil and non-digested proteins during liquid phase processing. Subsequent steps of solids and oil removal through various mechanical separation techniques are required to create a final fish protein fraction with acceptable organoleptic properties for use in human food. Minimization of odor through the elimination of fat and oil from the protein fraction, as well as separating out the lowest molecular weight protein fractions from the larger fractions all serve to create a refined fish protein. Some processes utilize solvents to extract the fat but these can result in dangerous handling and potential residual issues. The final step in producing the product is typically spray drying, which involves atomizing the liquid protein in a hot air chamber resulting in rapid evaporation of the water and a fine powder falling to the bottom of the chamber for removal.
Before the occupation, Jews in the area had become targeted during the Holocaust in the Sudetenland. Only a few weeks later, the Kristallnacht occurred. As elsewhere in Germany, many synagogues were set on fire and numerous leading Jews were sent to concentration camps. Jews and Czechs were not the only afflicted peoples since German socialists, communists and pacifists were widely persecuted as well. Some of the German socialists fled the Sudetenland via Prague and London to other countries. The Gleichschaltung would permanently alter the community in the Sudetenland. However, on 4 December 1938, there were elections in Reichsgau Sudetenland in which 97.32% of the adult population voted for the NSDAP. About a half million Sudeten Germans joined the Nazi Party, 17.34% of the total German population in the Sudetenland (the average NSDAP membership participation in Germany was merely 7.85% in 1944). That means the Sudetenland was one of the most pro-Nazi regions of Nazi Germany. Because of their knowledge of the Czech language, many Sudeten Germans were employed in the administration of the ethnic Czech Protectorate of Bohemia and Moravia as well as in Nazi organizations (Gestapo etc.). The most notable one was Karl Hermann Frank, the SS and police general and Secretary of State in the Protectorate. Nazi Germany occupied Sudetenland from 1938 to 1945. The annexation was supported by many Bohemian and Moravian Germans.
=== Post-independence (1946–1962) === The first elections after independence were the 1947 parliamentary election, with the People's Party winning a plurality in the Chamber of Deputies, but no absolute majority. In 1949, a series of military coups led to the dissolution of the Chamber of Deputies and constitutional suspensions. A Constituent Assembly elected in 1949 drafted the 1950 constitution, which strengthened parliamentary powers. Adib al-Shishakli's 1951 coup dissolved the Chamber of Deputies, and his 1953 election, with only 16% voter turnout, reconstituted the Chamber of Deputies as a 82-member legislative body under a presidential system. After his ouster in 1954, parliamentary rule was restored, with the People's Party and Ba'ath Party gaining influence. In 1958, the Chamber of Deputies was replaced by the UAR's National Assembly, where Syrians held one-third of the seats. Following Syria's withdrawal, the 1961 election restored parliamentary democracy.
Nuclear factor erythroid 2-related factor 2, also known as NFE2-Related Factor 2 (NRF2) or nuclear factor erythroid-derived 2-like 2 (NFE2L2), is a transcription factor that in humans is encoded by the NFE2L2 gene. NRF2 is a basic leucine zipper (bZIP) protein that may regulate the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation, according to preliminary research. In vitro, NRF2 binds to antioxidant response elements (AREs) in the promoter regions of genes encoding cytoprotective proteins. NRF2 induces the expression of heme oxygenase 1 in vitro leading to an increase in phase II enzymes. NRF2 also inhibits the NLRP3 inflammasome. NRF2 appears to participate in a complex regulatory network and performs a pleiotropic role in the regulation of metabolism, inflammation, autophagy, proteostasis, mitochondrial physiology, and immune responses. Several drugs that stimulate the NFE2L2 pathway are being studied for treatment of diseases that are caused by oxidative stress.
Sources: en.wikipedia.org
== Consciousness and dreaming == Initially, dreaming was thought to only occur in rapid eye movement sleep, though it is now known that dreaming may also occur during slow-wave sleep. Delta waves and delta wave activity are marked, in most people, by an apparently unconscious state, and the loss of physical awareness as well as the "iteration of information". Delta wave activity has also been purported to aid in declarative and explicit memory formation.
Luvesilocin, also known as RE104 and FT-104, as well as 4-glutaryloxy-N,N-diisopropyltryptamine (4-HO-DiPT O-glutarate or 4-GO-DiPT), is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families which is under development for the treatment of psychiatric disorders. It is taken orally or by subcutaneous injection. The drug is a prodrug ester of 4-HO-DiPT, which acts as a non-selective serotonin receptor agonist including of the serotonin 5-HT2A receptor. Luvesilocin was first described in the literature in 2021. It is under development for the treatment of postpartum depression and treatment-resistant depression. As of September 2025, the drug has reached phase 2 clinical trials. A phase 3 trial is planned for 2026.
The authentic idea of the unity of the Slavic people was all but gone after World War I, described with the maxim "Versailles and Trianon have put an end to all Slavisms". During the Cold War, all Slavic peoples were in union under the dominance of the USSR, but pan-Slavism was rejected as reactionary to Communist ideals, and this unity was largely put to rest with the fall of communism in Central and Eastern Europe in the late 1980s, leading to the breakup of federal states such as Czechoslovakia and Yugoslavia. Varying relations between the Slavic countries exist nowadays; they range from mutual respect on equal footing and sympathy towards one another through traditional dislike and enmity, to indifference. No forms, other than culture and heritage oriented organizations, are currently considered forms of rapprochement among the countries with Slavic origins. The political parties which include Pan-Slavism as part of their program usually live on the fringe of the political spectrum, or are part of controlled and systemic opposition in Belarus, Russia and occupied territories, as part of an irredentist pan-slavist campaign by Russia. A political concept of Euro-Slavism evolved from the idea that European integration will solve issues of Slavic peoples and promote peace, unity and cooperation on equal terms within the European Union. The concept seeks to resist strong multicultural tendencies from Western Europe, the dominant position of Germany, opposes Slavophilia, and typically encourages democracy and democratic values.
Mayer's reagent is an alkaloidal precipitating reagent used for the detection of alkaloids in natural products. Mayer's reagent is freshly prepared by dissolving a mixture of mercuric chloride (1.36 g) and of potassium iodide (5.00 g) in water (100.0 ml). Most alkaloids are precipitated from neutral or slightly acidic solution by Mayer's reagent (potassiomercuric iodide solution) to give a cream coloured precipitate. This test was invented by and named after the German chemist Julius Robert Von Mayer (1814–1878). Can be used as a visualization reagent in thin-layer chromatography (TLC) for the detection of alkaloids.
Some anesthetics and chemotherapy drugs are injected intrathecally into the subarachnoid space, where they spread around CSF, meaning substances that cannot cross the blood–brain barrier can still be active throughout the central nervous system. Baricity refers to the density of a substance compared to the density of human cerebrospinal fluid and is used in regional anesthesia to determine the manner in which a particular drug will spread in the intrathecal space. Liquorpheresis is the process of filtering the CSF in order to clear it from endogen or exogen pathogens. It can be achieved by means of fully implantable or extracorporeal devices, though the technique remains experimental today.
Sources: en.wikipedia.org
It is synthesized from lathosterol by the enzyme lathosterol oxidase (lathosterol 5-desaturase). This is the next-to-last step of cholesterol biosynthesis. Defective synthesis results in the human inherited disorder lathosterolosis resembling Smith–Lemli–Opitz syndrome. Mice where this gene has been deleted lose the ability to increase vitamin D3 in the blood following UV exposure of the skin. The skin consists of two primary layers: an inner layer, the dermis, comprising largely connective tissue, and an outer, thinner epidermis. The thickness of the epidermis ranges from 0.04 mm to greater than 0.6 mm. The epidermis comprises five strata; from outer to inner, they are the stratum corneum, stratum lucidum, stratum granulosum, stratum spinosum, and stratum basale. The highest concentrations of 7-dehydrocholesterol are found in the epidermal layer of skin—specifically in the stratum basale and stratum spinosum. The production of pre-vitamin D3 is, therefore, greatest in these two layers.
Loading buffers often contain anionic dyes that are visible under the visible light spectrum, and are added to the gel before the nucleic acid. Tracking dyes should not be reactive so as not to alter the sample, and move down the gel with the DNA or RNA sample. Commonly used color markers include Bromophenol blue, Cresol Red, Orange G and Xylene cyanol. Xylene and bromophenol blue are the most commonly used dyes. Generally speaking, Orange G migrates faster than bromophenol blue, which migrates faster than xylene cyanol, but the apparent "sizes" of these dyes (compared to DNA molecules) varies with the concentration of agarose and the buffer system used. For instance, in a 1% agarose gel made in TAE buffer (Tris-acetate-EDTA), xylene cyanol migrates at the speed of a 3000 base pair (bp) molecule of DNA and bromophenol blue migrates at 400 bp. However, in a 1% gel made in TBE buffer (Tris-borate-EDTA), they migrate at 2000 bp and 250 bp respectively.
The issue has a similar format to the previous volume in that each game in the list has a retrospective article accompanied by a full-page illustration (often a piece of concept art from the game). The list was composed solely by Edge staff; there are no sidebars with readers' comments. The "Top 100" lists contained in the 2007 volume were not reprinted. The criteria Edge used when compiling the list were simple: games from any platform were eligible, series featuring straight-up sequels could only include a single entry, and the games in the list "had to stand up today rather than making the cut for reasons of nostalgia or historic significance." The top 10 of the 100 greatest videogames were: Dark Souls Grand Theft Auto V The Last of Us Bloodborne Half-Life 2 Tetris Super Mario Galaxy 2 The Legend of Zelda: Ocarina of Time Resident Evil 4 Minecraft An Edge Special Edition - "the 100 greatest videogames" (2017)
== External links == "Rosiglitazone". MedlinePlus. U.S. National Library of Medicine. Peck P (20 July 2004). "Rosiglitazone May Improve Function in Patients With Mild Alzheimer's Disease". Medscape. "Rosiglitazone". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on May 11, 2009.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.